Prior use of four invasive procedures increases the risk of Acinetobacter baumannii nosocomial bacteremia among patients in intensive care units: a systematic review and meta-analysis

Falagas, 2008, Acinetobacter infections: a growing threat for critically ill patients, Epidemiol Infect, 136, 1009, 10.1017/S0950268807009478 Giamarellou, 2008, Acinetobacter baumannii: a universal threat to public health?, Int J Antimicrob Agents, 32, 106, 10.1016/j.ijantimicag.2008.02.013 Cerqueira, 2011, Insights into Acinetobacter baumannii pathogenicity, IUBMB Life, 63, 1055, 10.1002/iub.533 Bergogne-Bérézin, 1996, Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features, Clin Microbiol Rev, 9, 148, 10.1128/CMR.9.2.148 Forster, 1998, Acinetobacter species as nosocomial pathogens, Eur J Clin Microbiol Infect Dis, 17, 73, 10.1007/BF01682159 Valles, 1997, Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC), Clin Infect Dis, 24, 387, 10.1093/clinids/24.3.387 Blot, 2003, Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study, Intensive Care Med, 29, 471, 10.1007/s00134-003-1648-8 García-Garmendia, 2001, Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study, Clin Infect Dis, 33, 939, 10.1086/322584 Wisplinghoff, 1999, Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case–control study of adult burn patients, Clin Infect Dis, 28, 59, 10.1086/515067 Kim, 2012, Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit, J Korean Med Sci, 27, 939, 10.3346/jkms.2012.27.8.939 Jang, 2009, Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case–control study, J Hosp Infect, 73, 143, 10.1016/j.jhin.2009.06.007 Jung, 2010, Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit, BMC Infect Dis, 10, 228, 10.1186/1471-2334-10-228 Rello, 1999, Acinetobacter baumannii infections in the ICU: customization is the key, Chest, 115, 1226, 10.1378/chest.115.5.1226 Garner, 1988, CDC definitions for nosocomial infections, 1988, Am J Infect Control, 16, 128, 10.1016/0196-6553(88)90053-3 Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [web page]. Available at: Ottawa Hospital Research Institute. Research Programs. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration; 2011. Cisneros, 2002, Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment, Clin Microbiol Infect, 8, 687, 10.1046/j.1469-0691.2002.00487.x Wisplinghoff, 2004, Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study, Clin Infect Dis, 39, 309, 10.1086/421946 Munoz-Price, 2008, Acinetobacter infection, N Engl J Med, 358, 1271, 10.1056/NEJMra070741 Joly-Guillou, 2005, Clinical impact and pathogenicity of Acinetobacter, Clin Microbiol Infect, 11, 868, 10.1111/j.1469-0691.2005.01227.x Wisplinghoff, 2000, Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility, Clin Infect Dis, 31, 690, 10.1086/314040 Trottier, 2007, Outcomes of Acinetobacter baumannii infection in critically ill surgical patients, Surg Infect (Larchmt), 8, 437, 10.1089/sur.2006.029 Seifert, 1997, Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods, J Clin Microbiol, 35, 2819, 10.1128/JCM.35.11.2819-2825.1997 Howard, 2012, Acinetobacter baumannii: an emerging opportunistic pathogen, Virulence, 3, 243, 10.4161/viru.19700 Gaddy, 2009, Regulation of Acinetobacter baumannii biofilm formation, Future Microbiol, 4, 273, 10.2217/fmb.09.5 Lorente, 2002, Prevention of infection in the intensive care unit: current advances and opportunities for the future, Curr Opin Crit Care, 8, 461, 10.1097/00075198-200210000-00015